- Home
- ZCMD vs COEP Comparison
ZCMD vs COEP Comparison
Compare ZCMD & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- COEP
- Stock Information
- Founded
- ZCMD 2012
- COEP 2017
- Country
- ZCMD China
- COEP United States
- Employees
- ZCMD N/A
- COEP 7
- Industry
- ZCMD Other Consumer Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZCMD Real Estate
- COEP Health Care
- Exchange
- ZCMD Nasdaq
- COEP Nasdaq
- Market Cap
- ZCMD 32.8M
- COEP 32.0M
- IPO Year
- ZCMD 2020
- COEP N/A
- Fundamental
- Price
- ZCMD $1.29
- COEP $9.81
- Analyst Decision
- ZCMD
- COEP
- Analyst Count
- ZCMD 0
- COEP 0
- Target Price
- ZCMD N/A
- COEP N/A
- AVG Volume (30 Days)
- ZCMD 9.9K
- COEP 103.6K
- Earning Date
- ZCMD 01-01-0001
- COEP 05-27-2025
- Dividend Yield
- ZCMD N/A
- COEP N/A
- EPS Growth
- ZCMD N/A
- COEP N/A
- EPS
- ZCMD N/A
- COEP N/A
- Revenue
- ZCMD $15,864,773.00
- COEP $62,874.00
- Revenue This Year
- ZCMD N/A
- COEP N/A
- Revenue Next Year
- ZCMD N/A
- COEP N/A
- P/E Ratio
- ZCMD N/A
- COEP N/A
- Revenue Growth
- ZCMD N/A
- COEP N/A
- 52 Week Low
- ZCMD $0.95
- COEP $2.31
- 52 Week High
- ZCMD $2.97
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- ZCMD 56.70
- COEP 52.99
- Support Level
- ZCMD $1.15
- COEP $9.11
- Resistance Level
- ZCMD $1.29
- COEP $10.86
- Average True Range (ATR)
- ZCMD 0.09
- COEP 1.05
- MACD
- ZCMD 0.01
- COEP 0.12
- Stochastic Oscillator
- ZCMD 90.54
- COEP 67.32
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.